Fatal Breakthrough Candidemia in an Immunocompromised Patient in Kuwait Due to Candida auris Exhibiting Reduced Susceptibility to Echinocandins and Carrying a Novel Mutation in Hotspot-1 of FKS1

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200 · see citing works

Simultaneous Emergence of Multidrug-Resistant <i>Candida auris</i> on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662 · see citing works

Invasive candidiasis

Kullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315 · see citing works

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016

Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825 · see citing works

Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment

Arendrup, M. C., & Patterson, T. F. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix131 · Cited by 707 · see citing works

The Competitive Cost of Antibiotic Resistance in <i>Mycobacterium tuberculosis</i>

Gagneux, S., Long, C. D., Small, P. M., Van, T., Schoolnik, G. K., & Bohannan, B. J. M. (2006) · Science · doi:10.1126/science.1124410 · Cited by 627 · see citing works

A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance

Chowdhary, A., Prakash, A., Sharma, C., Kordalewska, M., Kumar, A., Sarma, S., Tarai, B., Singh, A., Upadhyaya, G., Upadhyay, S., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx480 · Cited by 577 · see citing works

Changes in the epidemiological landscape of invasive candidiasis

Lamoth, F., Lockhart, S. R., Berkow, E. L., & Calandra, T. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx444 · Cited by 547 · see citing works

Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens

Friedman, D. Z. P., & Schwartz, I. S. (2019) · Journal of Fungi · doi:10.3390/jof5030067 · Cited by 357 · see citing works

Potential Fifth Clade of <i>Candida auris,</i> Iran, 2018

Chow, N. A., de Groot, T., Badali, H., Abastabar, M., Chiller, T. M., & Meis, J. F. (2019) · Emerging Infectious Diseases · doi:10.3201/eid2509.190686 · Cited by 356 · see citing works

Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis: A Systematic Review

Seifert, M., Catanzaro, D. G., Catanzaro, A., & Rodwell, T. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119628 · Cited by 326 · see citing works

Diagnosing invasive candidiasis

Clancy, C. J., & Nguyen, M. H. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01909-17 · Cited by 293 · see citing works

Performance of Candida Real-time Polymerase Chain Reaction, -D-Glucan Assay, and Blood Cultures in the Diagnosis of Invasive Candidiasis

Nguyen, M. H., Wissel, M. C., Shields, R. K., Salomoni, M. A., Hao, B., Press, E. G., Shields, R. M., Cheng, S., Mitsani, D., Vadnerkar, A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis200 · Cited by 290 · see citing works

Invasive Candidiasis

McCarty, T. P., & Pappas, P. G. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.013 · Cited by 285 · see citing works

Candida auris: epidemiology, diagnosis, pathogenesis, antifungal susceptibility, and infection control measures to combat the spread of infections in healthcare facilities

Ahmad, S., & Alfouzan, W. (2021) · Microorganisms · doi:10.3390/microorganisms9040807 · Cited by 269 · see citing works

Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris

Kordalewska, M., Lee, A., Park, S., Berrio, I., Chowdhary, A., Zhao, Y., & Perlin, D. S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00238-18 · Cited by 247 · see citing works

Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen <i>Candida auris</i>

Rhodes, J., Abdolrasouli, A., Farrer, R. A., Cuomo, C. A., Aanensen, D. M., Armstrong-James, D., Fisher, M. C., & Schelenz, S. (2018) · Emerging Microbes &amp; Infections · doi:10.1038/s41426-018-0045-x · Cited by 246 · see citing works

Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology

Cornely, O. A., Hoenigl, M., Lass‐Flörl, C., Chen, S. C. ‐., Kontoyiannis, D. P., Morrissey, C. O., & Thompson, G. R. (2019) · Mycoses · doi:10.1111/myc.12960 · Cited by 224 · see citing works

Mutations in <i>TAC1B</i> : a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris

Rybak, J. M., Muñoz, J. F., Barker, K. S., Parker, J. E., Esquivel, B. D., Berkow, E. L., Lockhart, S. R., Gade, L., Palmer, G. E., White, T. C., et al. (2020) · mBio · doi:10.1128/mbio.00365-20 · Cited by 202 · see citing works

Breakthrough invasive fungal infections: Who is at risk?

Jenks, J. D., Cornely, O. A., Chen, S. C. ‐., Thompson, G. R., & Hoenigl, M. (2020) · Mycoses · doi:10.1111/myc.13148 · Cited by 191 · see citing works

Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris

Chen, J., Tian, S., Han, X., Chu, Y., Wang, Q., Zhou, B., & Shang, H. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05543-0 · Cited by 159 · see citing works

Epidemiologic Shift in Candidemia Driven by <i>Candida auris</i>, South Africa, 2016–20171

van Schalkwyk, E., Mpembe, R. S., Thomas, J., Shuping, L., Ismail, H., Lowman, W., Karstaedt, A. S., Chibabhai, V., Wadula, J., Avenant, T., et al. (2019) · Emerging Infectious Diseases · doi:10.3201/eid2509.190040 · Cited by 137 · see citing works

In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris

Rybak, J. M., Barker, K. S., Muñoz, J. F., Parker, J. E., Ahmad, S., Mokaddas, E., Abdullah, A., Elhagracy, R. S., Kelly, S. L., Cuomo, C. A., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.11.024 · Cited by 120 · see citing works

Treatment of Invasive Candidiasis: A Narrative Review

Ben-Ami, R. (2018) · Journal of Fungi · doi:10.3390/jof4030097 · Cited by 111 · see citing works

Colonisation and Transmission Dynamics of Candida auris among Chronic Respiratory Diseases Patients Hospitalised in a Chest Hospital, Delhi, India: A Comparative Analysis of Whole Genome Sequencing and Microsatellite Typing

Yadav, A., Singh, A. K., Wang, Y., van Haren, M. H. I., Singh, A. K., de Groot, T., Meis, J. F. G. M., Xu, J., & Chowdhary, A. (2021) · Journal of Fungi · doi:10.3390/jof7020081 · Cited by 111 · see citing works

Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris

Berkow, E. L., & Lockhart, S. R. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.10.021 · Cited by 110 · see citing works

Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait

Khan, Z., Ahmad, S., Al-Sweih, N., Joseph, L., Alfouzan, W., & Asadzadeh, M. (2018) · PLOS ONE · doi:10.1371/journal.pone.0195743 · Cited by 109 · see citing works

Outbreak of Fungemia among Neonates Caused by Candida haemulonii Resistant to Amphotericin B, Itraconazole, and Fluconazole

Khan, Z. U., Al‐Sweih, N., Ahmad, S., Al-Kazemi, N., Khan, S. I., Joseph, L., & Chandy, R. G. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00222-07 · Cited by 105 · see citing works

Candida auris candidaemia in an intensive care unit - Prospective observational study to evaluate epidemiology, risk factors, and outcome

Shastri, P. S., Shankarnarayan, S. A., Oberoi, J., Rudramurthy, S. M., Wattal, C., & Chakrabarti, A. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.01.004 · Cited by 103 · see citing works

Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis

Ahmad, S., & Mokaddas, E. M. (2013) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2013.09.001 · Cited by 98 · see citing works

Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients

Gaitán, A. C. R., Martínez, H., Moret, A. M., Calabuig, E., Tasias, M., Alastruey‐Izquierdo, A., Zaragoza, Ó., Mollar, J., Frasquet, J., Salavert, M., et al. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1592675 · Cited by 93 · see citing works

Five‐year profile of candidaemia at an Indian trauma centre: High rates of Candida auris blood stream infections

Mathur, P., Hasan, M. F., Singh, P. K., Malhotra, R., Walia, K., & Chowdhary, A. (2018) · Mycoses · doi:10.1111/myc.12790 · Cited by 86 · see citing works

ERG6 and ERG2 Are Major Targets Conferring Reduced Susceptibility to Amphotericin B in Clinical Candida glabrata Isolates in Kuwait

Ahmad, S., Joseph, L., Parker, J. E., Asadzadeh, M., Kelly, S. L., Meis, J. F. G. M., & Khan, Z. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01900-18 · Cited by 83 · see citing works

Candida auris outbreak: Mortality, interventions and cost of sustaining control

Taori, S. K., Khonyongwa, K., Hayden, I., Athukorala, G. D. A., Letters, A., Fife, A., Desai, N., & Borman, A. M. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.09.007 · Cited by 83 · see citing works

Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs

Ahmad, S., Khan, Z., Al‐Sweih, N., Alfouzan, W. A., & Joseph, L. (2019) · Mycoses · doi:10.1111/myc.13022 · Cited by 78 · see citing works

Molecular Epidemiology of Candida Auris Outbreak in a Major Secondary-Care Hospital in Kuwait

Alfouzan, W. A., Ahmad, S., Dhar, R., Asadzadeh, M., Merdasi, N. A., Abdo, N. M., Joseph, L., de Groot, T., Alali, W. Q., Khan, Z., et al. (2020) · Journal of Fungi · doi:10.3390/jof6040307 · Cited by 76 · see citing works

Invasive candidiasis: A review of nonculture-based laboratory diagnostic methods

Ahmad, S., & Khan, Z. U. (2012) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.99482 · Cited by 67 · see citing works

Changing trends in epidemiology and antifungal susceptibility patterns of six bloodstream Candida species isolates over a 12-year period in Kuwait

Khan, Z., Ahmad, S., Al‐Sweih, N., Mokaddas, E. M., Al-Banwan, K., Alfouzan, W. A., Al‐Obaid, I., Alobaid, K., Asadzadeh, M., Jeragh, A., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216250 · Cited by 65 · see citing works

Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUN gal infections Definitions in ICU patients ( FUNDICU ) project

Bassetti, M., Scudeller, L., Giacobbe, D. R., Lamoth, F., Righi, E., Zuccaro, V., Grecchi, C., Rebuffi, C., Akova, M., Alastruey‐Izquierdo, A., et al. (2018) · Mycoses · doi:10.1111/myc.12869 · Cited by 64 · see citing works

Characteristics and Management of Candidaemia Episodes in an Established Candida auris Outbreak

Bayona, J. V. M., Tormo, N., García, C. S., Rodríguez, P. H., de Medrano, V. A. L., Gómez, C. F., & Cardona, C. G. (2020) · Antibiotics · doi:10.3390/antibiotics9090558 · Cited by 62 · see citing works

Impact of <i>FKS1</i> Genotype on Echinocandin <i>In Vitro</i> Susceptibility in Candida auris and <i>In Vivo</i> Response in a Murine Model of Infection

Sharma, D., Paul, R. A., Rudramurthy, S. M., Kashyap, N., Bhattacharya, S., Soman, R., Shankarnarayan, S. A., Chavan, D., Singh, S., Das, P., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01652-21 · Cited by 60 · see citing works

Cryptococcus randhawai sp. nov., a novel anamorphic basidiomycetous yeast isolated from tree trunk hollow of Ficus religiosa (peepal tree) from New Delhi, India

Khan, Z. U., Ahmad, S., Hagen, F., Fell, J. W., Kowshik, T., Chandy, R. G., & Boekhout, T. (2009) · Antonie van Leeuwenhoek · doi:10.1007/s10482-009-9406-8 · Cited by 59 · see citing works

Molecular characterisation of <i>Candida auris</i> isolates from immunocompromised patients in a tertiary‐care hospital in Kuwait reveals a novel mutation in <i>FKS1</i> conferring reduced susceptibility to echinocandins

Asadzadeh, M., Mokaddas, E., Ahmad, S., Abdullah, A. A., de Groot, T., Meis, J. F., & Shetty, S. A. (2022) · Mycoses · doi:10.1111/myc.13419 · Cited by 55 · see citing works

Simple, Low-Cost Detection of Candida parapsilosis Complex Isolates and Molecular Fingerprinting of Candida orthopsilosis Strains in Kuwait by ITS Region Sequencing and Amplified Fragment Length Polymorphism Analysis

Asadzadeh, M., Ahmad, S., Hagen, F., Meis, J. F. G. M., Al‐Sweih, N., & Khan, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142880 · Cited by 54 · see citing works

Clinical Outcomes of Patients Treated for Candida auris Infections in a Multisite Health System, Illinois, USA

Hannan, K. N. A., Miller, J. L., Chiang, A., Mai, N., Levato, J., LaChance, E., Anderson, M., Beganovic, M., & Dela‐Pena, J. (2020) · Emerging infectious diseases · doi:10.3201/eid2605.191588 · Cited by 52 · see citing works

Development of Echinocandin Resistance in Candida tropicalis following Short-Term Exposure to Caspofungin for Empiric Therapy

Khan, Z., Ahmad, S., Mokaddas, E. M., Meis, J. F. G. M., Joseph, L., Abdullah, A. A., & Vayalil, S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01926-17 · Cited by 42 · see citing works

Micafungin breakthrough fungemia in patients with hematological disorders

Kimura, M., Araoka, H., Yamamoto, H., Nakamura, S., Nagi, M., Yamagoe, S., Miyazaki, Y., Ogura, S., Mitsuki, T., Yuasa, M., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02183-17 · Cited by 37 · see citing works

Candida lusitaniae in Kuwait: Prevalence, antifungal susceptibility and role in neonatal fungemia

Khan, Z., Ahmad, S., Al‐Sweih, N., Khan, S. I., & Joseph, L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213532 · Cited by 35 · see citing works

Candida kefyr in Kuwait: Prevalence, antifungal drug susceptibility and genotypic heterogeneity

Ahmad, S., Khan, Z., Al‐Sweih, N., Alfouzan, W. A., Joseph, L., & Asadzadeh, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240426 · Cited by 33 · see citing works

Clinical Characteristics and Outcomes of Breakthrough Candidemia in 71 Hematologic Malignancy Patients and/or Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Single-center Retrospective Study From China, 2011–2018

Chen, X.-C., Xu, J., & Wu, D.-P. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1523 · Cited by 32 · see citing works

Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis

Posteraro, B., Carolis, E. D., Criscuolo, M., Ballanti, S., Angelis, G. D., Principe, M. I. D., Delia, M., Fracchiolla, N., Marchesi, F., Nadali, G., et al. (2020) · Mycoses · doi:10.1111/myc.13130 · Cited by 30 · see citing works

Breakthrough Invasive Candida glabrata in Patients on Micafungin: a Novel FKS Gene Conversion Correlated with Sequential Elevation of MIC

Saraya, T., Tanabe, K., Araki, K., Yonetani, S., Makino, H., Watanabe, T., Tsujimoto, N., Takata, S., Kurai, D., Ishii, H., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03593-13 · Cited by 22 · see citing works

Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant Candida tropicalis: An Emerging Threat to Immunocompromised Patients with Hematological Malignancies

Sfeir, M. M., Jiménez-Ortigosa, C., Gamaletsou, M. N., Schuetz, A. N., Soave, R., Van Besien, K., Small, C. B., Perlin, D. S., & Walsh, T. J. (2020) · Journal of Fungi · doi:10.3390/jof6010020 · Cited by 19 · see citing works

Antifungal Prophylaxis: Why, What and How?

Lyon, S. (2015) · Future Microbiology · doi:10.2217/fmb.15.129 · Cited by 5 · see citing works

In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida aurisPreprint

Rybak, J. M., Barker, K. S., Muñoz, J. F., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.08.463721 · Cited by 2 · see citing works

Molecular mechanisms governing antifungal drug resistance

Lee, Y., Robbins, N., & Cowen, L. E. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00007-2 · Cited by 304 · see citing works

The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida auris

Rybak, J. M., Cuomo, C. A., & David Rogers, P. (2022) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102208 · Cited by 113 · see citing works

Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris <i>:</i> Results from a Phase 2 Trial

Vazquez, J. A., Pappas, P. G., Boffard, K., Paruk, F., Bien, P. A., Tawadrous, M., Ople, E., Wedel, P., Oborska, I., & Hodges, M. R. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01419-22 · Cited by 92 · see citing works

Strategies to Prevent Transmission of Candida auris in Healthcare Settings

Ahmad, S., & Asadzadeh, M. (2023) · Current Fungal Infection Reports · doi:10.1007/s12281-023-00451-7 · Cited by 84 · see citing works

Whole genome sequencing analysis demonstrates therapy‐induced echinocandin resistance in <i>Candida auris</i> isolates

Spruijtenburg, B., Ahmad, S., Asadzadeh, M., Alfouzan, W., Al‐Obaid, I., Mokaddas, E., Meijer, E. F. J., Meis, J. F., & de Groot, T. (2023) · Mycoses · doi:10.1111/myc.13655 · Cited by 61 · see citing works

Perspective on the origin, resistance, and spread of the emerging human fungal pathogen Candida auris

Sharma, C., & Kadosh, D. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011190 · Cited by 59 · see citing works

Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation

Siopi, M., Peroukidou, I., Beredaki, M.-I., Spruijtenburg, B., de Groot, T., Meis, J. F. G. M., Vrioni, G., Tsakris, A., Pournaras, S., & Meletiadis, J. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04431-22 · Cited by 44 · see citing works

Candida auris from colonisation to candidemia: A four‐year study

Bayona, J. V. M., Tormo, N., García, C. S., Serrano, M. D. R. G., & Cardona, C. G. (2023) · Mycoses · doi:10.1111/myc.13626 · Cited by 36 · see citing works

Evaluation of the Vitek 2 system for antifungal susceptibility testing of Candida auris using a representative international panel of clinical isolates: overestimation of amphotericin B resistance and underestimation of fluconazole resistance

Siopi, M., Pachoulis, I., Leventaki, S., Spruijtenburg, B., Meis, J. F. G. M., Pournaras, S., Vrioni, G., Tsakris, A., & Meletiadis, J. (2024) · Journal of Clinical Microbiology · doi:10.1128/jcm.01528-23 · Cited by 32 · see citing works

Global Epidemiology of Invasive Infections by Uncommon Candida Species: A Systematic Review

Pinho, S., Miranda, I. M., & Costa‐de‐Oliveira, S. (2024) · Journal of Fungi · doi:10.3390/jof10080558 · Cited by 35 · see citing works

Novel Non-Hot Spot Modification in Fks1 of Candida auris Confers Echinocandin Resistance

Kordalewska, M., Cancino-Prado, G., de Almeida, J. N., Brandão, I. B., Peral, R. T. D. S., Colombo, A. L., & Perlin, D. S. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00423-23 · Cited by 29 · see citing works

Efficacy of the combination of amphotericin B and echinocandins against Candida auris in vitro and in the Caenorhabditis elegans host model

Hernando-Ortiz, A., Eraso, E., Jauregizar, N., de Groot, P. W. J., Quindós, G., & Mateo, E. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02086-23 · Cited by 22 · see citing works

The multidrug-resistant Candida auris, Candida haemulonii complex and phylogenetic related species: Insights into antifungal resistance mechanisms

Ramos, L. S., Barbosa, P. F., Lorentino, C. M. A., Lima, J. C., Braga, A. L., Lima, R., Giovanini, L., Casemiro, A. L., Siqueira, N. L. M., da Costa, S. C., et al. (2025) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2025.100354 · Cited by 24 · see citing works

A Mini-Review of In Vitro Data for Candida Species, Including C. auris, Isolated during Clinical Trials of Three New Antifungals: Fosmanogepix, Ibrexafungerp, and Rezafungin

Espinel‐Ingroff, A., & Wiederhold, N. P. (2024) · Journal of Fungi · doi:10.3390/jof10050362 · Cited by 18 · see citing works

Challenges in the diagnosis and treatment of candidemia due to multidrug-resistant Candida auris

Giacobbe, D. R., Mikulska, M., Vena, A., Pilato, V. D., Magnasco, L., Marchese, A. E., & Bassetti, M. (2023) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2023.1061150 · Cited by 19 · see citing works

Global prevalence of multidrug-resistant Candida auris in humans between 2015 and 2024: A systematic review and meta-analysis

Achilonu, C. C., Barwatt, W. J., Kottom, T. J., Oladele, R. O., Ramatla, T. A., & LIMPER, A. H. (2025) · Medical Mycology · doi:10.1093/mmy/myaf107 · Cited by 15 · see citing works

Synergistic Interaction of Caspofungin Combined with Posaconazole against FKS Wild-Type and Mutant Candida auris Planktonic Cells and Biofilms

Balla, N., Kovács, F., Balázs, B., Borman, A. M., Bozó, A., Jakab, Á., Tóth, Z., Kobaissi, O., Majoros, L., & Kovács, R. (2022) · Antibiotics · doi:10.3390/antibiotics11111601 · Cited by 15 · see citing works

Molecular Characterization and Sterol Profiles Identify Nonsynonymous Mutations in ERG2 as a Major Mechanism Conferring Reduced Susceptibility to Amphotericin B in Candida kefyr

Asadzadeh, M., Alfouzan, W. A., Parker, J. E., Meis, J. F. G. M., Kelly, S. L., Joseph, L., & Ahmad, S. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01474-23 · Cited by 15 · see citing works

Comparative transcriptional analysis of Candida auris biofilms following farnesol and tyrosol treatment

Jakab, Á., Kovács, F., Balla, N., Nagy-Köteles, C., Ragyák, Á. Z., Nagy, F., Borman, A. M., Majoros, L., & Kovács, R. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.02278-23 · Cited by 11 · see citing works

Genotypic and phenotypic characterisation of a nosocomial outbreak of Candida auris in Spain during 5 years

Bayona, J. V. M., Cancino‐Muñoz, I., García, C. S., Tormo, N., Serrano, M. D. R. G., Ferrer‐Gómez, C., García, M. M. M., Gónzález‐Candelas, F., & Gimeno-Cardona, C. (2024) · Mycoses · doi:10.1111/myc.13776 · Cited by 11 · see citing works

A Candidozyma ( Candida ) auris– Optimized Episomal Plasmid–Induced Cas9-Editing System Reveals the Direct Impact of the S639F-Encoding FKS1 Mutation

Doorley, L. A., Meza-Perez, V., Jones, S. J., & Rybak, J. M. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf285 · Cited by 10 · see citing works

Epidemiology of Candidemia, Candiduria and Emerging Candidozyma (Candida) auris Across Gulf Cooperative Council Countries and Yemen in the Arabian Peninsula

Ahmad, S., Boekhout, T., Al‐Hatmi, A. M. S., Al‐Harrasi, A., Khateb, A. M., Dhaheri, F. A. A., Shuraym, H. B., Thomsen, J., Alobaid, K., Asadzadeh, M., et al. (2025) · Mycoses · doi:10.1111/myc.70073 · Cited by 10 · see citing works

Deciphering the multidrug resistance paradigm in Candida auris

Santana, D. J., Cauldron, N. C., Rogers, P. D., & Cuomo, C. A. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01062-24 · Cited by 7 · see citing works

Molecular fingerprinting by multi-locus sequence typing identifies microevolution and nosocomial transmission of Candida glabrata in Kuwait

Asadzadeh, M., Ahmad, S., Al‐Sweih, N., & Khan, Z. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1242622 · Cited by 7 · see citing works

Identification and antifungal resistance profiling of Candida (Candidozyma) auris in a tertiary hospital in Istanbul, Türkiye

Akkaya, Y., Erdin, B. N., Yılmaz, A. M., Kılıç, İ. H., & Toraman, Z. A. (2025) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2025.207 · Cited by 6 · see citing works

A study of genomic complexity underlying multidrug resistance in Candida auris strains in Thailand

Opassathian, K., Boonmee, N., Swangkaew, S., Jenjaroenpun, P., Wongsurawat, T., Kruasuwan, W., Ngamskulrungroj, P., & Mitrpant, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-25386-6 · Cited by 6 · see citing works

A Candidemia Case Caused by a Novel Drug-Resistant Candida auris with the Y132F Mutation in Erg11 in Mainland China

Xu, Z., Zhang, L., Han, R., Ding, C., Shou, H., Duan, X., & Zhang, S. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s409708 · Cited by 6 · see citing works

Spectrum and management of rare Candida /yeast infections in Kuwait in the Middle East

Ahmad, S., Asadzadeh, M., Al‐Sweih, N., & Khan, Z. (2024) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361241263733 · Cited by 5 · see citing works

Diagnostic and clinical management of Candida auris infections in immunocompromised patients

Posteraro, B., Cosio, T., Torelli, R., Carolis, E. D., Magrì, C., Posteraro, P., Angelis, G. D., & Sanguinetti, M. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2505567 · Cited by 5 · see citing works

Head-to-Head Comparison of Etest, MICRONAUT-AM EUCAST and Reference Broth Microdilution-Based CLSI Results for Candida kefyr Antifungal Susceptibility Testing: Implications for Detection of Reduced Susceptibility to Amphotericin B

Asadzadeh, M., Ahmad, S., Meis, J. F. G. M., Parker, J. E., & Alfouzan, W. A. (2025) · Journal of Fungi · doi:10.3390/jof11080570 · Cited by 3 · see citing works

Beyond intrinsic resistance: novel insights into the emergence and management of resistance acquired in Candida auris upon antifungal exposure

Fayed, B. E. (2026) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-026-05515-3 · Cited by 1 · see citing works

Genotypic and phenotypic characterization of a nosocomial outbreak of Candida auris in Spain during five yearsPreprint

Bayona, J. V. M., Cancino‐Muñoz, I., Salvador-García, C., Tormo, N., Guna, R., Gónzález‐Candelas, F., & Cardona, C. G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.01.582904 · Cited by 1 · see citing works

FKS1/2 -variant independent mechanisms underlying the emergence of resistance in echinocandin-refractory Candida auris infectionsPreprint

Gifford, H., Pradhan, A., Caswall, B. A., Murphy, S., Leaves, I., Edmondson, M. B., Chakraborty, T., Wilson, D., Taori, S. K., Gow, N. A. R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.17.700071 · Cited by 1 · see citing works

Characterization and Susceptibility Pattern of Candida Species from Various Clinical Samples in a Rural Tertiary Care Hospital

Warghade, A. P., Mudey, G., Meshram, S., Kombe, S., & Shaw, D. (2023) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.17.3.53

Antimicrobial Peptides as Eco-Innovative Therapeutics to Overcome Antifungal Pressure-Induced Resistance in Candida Infections

Fayed, B. (2026) · Current Microbiology · doi:10.1007/s00284-026-05105-8

Antifungal drug resistance in Candida auris: molecular mechanisms and emerging therapeutic approaches

Phan-Canh, T., Elbe‐Bürger, A., & Kuchler, K. (2026) · Trends in Microbiology · doi:10.1016/j.tim.2026.08.011

Investigation of suspected Candidozyma auris outbreaks in Malaysia using integrated genomic, clinical, and antifungal susceptibility analyses

Tan, X. T., Cheng, J. T., Tuang, W. X., Lee, H. G., Khamis, S. N., Sharizam, N. F. B. M., Liow, Y. L., Omar, M. K. I., Chong, C. Y., & Low, L. L. (2026) · Medical Mycology · doi:10.1093/mmy/myag109

FKS1/2-variant independent mechanisms underlying the emergence of resistance in echinocandin-refractory Candida auris infections

Gifford, H., Pradhan, A., Caswall, B. A., Murphy, S. E., Leaves, I., Edmondson, M. B., Chakraborty, T., Wilson, D., Taori, S. K., Gow, N. A. R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76954-x · Cited by 1 · see citing works

Candida auris in the Middle East and North Africa: From Emerging Threat to Regional Healthcare Challenge

Fayed, B. E. (2026) · Medical Sciences · doi:10.3390/medsci14060679

Molecular characterisation of <i>Candida auris</i> isolates from immunocompromised patients in a tertiary‐care hospital in Kuwait reveals a novel mutation in <i>FKS1</i> conferring reduced susceptibility to echinocandins

Asadzadeh, M., Mokaddas, E., Ahmad, S., Abdullah, A. A., de Groot, T., Meis, J. F., & Shetty, S. A. (2022) · Mycoses · doi:10.1111/myc.13419 · Cited by 55 · see citing works

Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris

Kordalewska, M., Lee, A., Park, S., Berrio, I., Chowdhary, A., Zhao, Y., & Perlin, D. S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00238-18 · Cited by 247 · see citing works

Novel Non-Hot Spot Modification in Fks1 of Candida auris Confers Echinocandin Resistance

Kordalewska, M., Cancino-Prado, G., de Almeida, J. N., Brandão, I. B., Peral, R. T. D. S., Colombo, A. L., & Perlin, D. S. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00423-23 · Cited by 29 · see citing works

Echinocandin Resistance in Candida auris Occurs in the Murine Gastrointestinal Tract Due to FKS1 Mutations

Hirayama, T., Miyazaki, T., Sumiyoshi, M., Yuya, I. T. O., Ashizawa, N., Takeda, K., Iwanaga, N., Takazono, T., Yamamoto, K., Izumikawa, K., et al. (2023) · Institutional Repositories DataBase (IRDB) · doi:10.1128/aac.01243-22

FKS1/2 -variant independent mechanisms underlying the emergence of resistance in echinocandin-refractory Candida auris infectionsPreprint

Gifford, H., Pradhan, A., Caswall, B. A., Murphy, S., Leaves, I., Edmondson, M. B., Chakraborty, T., Wilson, D., Taori, S. K., Gow, N. A. R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.17.700071 · Cited by 1 · see citing works